No Data
No Data
As of June 7, 2024, the number of shareholders of Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ) was 30,383.
On June 12th, Gelunhui reported that as of June 7, 2024, the number of shareholders of Gansu Longshen Rongfa Pharmaceutical Co., Ltd. (stock code 300534.SZ) reached 30,383.
Gansu Longshenrongfa Pharmaceutical Industry (300534.SZ): Its holding subsidiary has passed the review of specialized, special and new small and medium-sized enterprises in Gansu Province.
On June 6th, GeLong Hui reported that Gansu Longshenrongfa Pharmaceutical Co., Ltd. (300534.SZ), the controlling subsidiary of which, Gansu Pu'an Pharmaceutical Co., Ltd., recently received an announcement from the Gansu Provincial Department of Industry and Information Technology via the Industrial and Information Technology Bureau of Liangzhou District, Wuwei City, regarding the announcement of the list of small and medium-sized enterprises and verified enterprises that were awarded the 'specialized, special, and new' title in Gansu Province in 2024. Pu'an Pharmaceutical passed the review for small and medium-sized enterprises with 'specialized, special, and new' status in Gansu Province, and the valid period is three years from the announcement date.
Longshen Rongfa (300534.SZ) plans to pay 0.2 yuan for every 10 shares in 2023, excluding interest on June 6
Longshen Rongfa (300534.SZ) announced that the company plans to distribute 0.2 for every 10 shares to all shareholders in 2023...
Longshen Rongfa (300534.SZ): The holding subsidiary obtained the “Pharmaceutical Production License” after the replacement
On May 23, Gelonghui | Longshen Rongfa (300534.SZ) announced that the holding subsidiary Gansu Pu'an Pharmaceutical Co., Ltd. applied for changes to the original “Pharmaceutical Production License” due to the addition of the traditional Chinese medicine pre-treatment workshop III, traditional Chinese medicine extraction workshop II and formulation workshop III, and recently received a “Pharmaceutical Production License” from the Gansu Drug Administration.
Pu'an Pharmaceutical, a subsidiary of Longshen Rongfa (300534.SZ) holding, passed the drug GMP compliance inspection
Longshen Rongfa (300534.SZ) announced that Gansu Pu'an Pharmaceutical Co., Ltd., a holding subsidiary of the company (abbreviation “...
Longshen Rongfa (300534.SZ): The holding subsidiary Pu'an Pharmaceutical passed the drug GMP compliance inspection
Gelonghui May 22丨Longshen Rongfa (300534.SZ) announced that Gansu Pu'an Pharmaceutical Co., Ltd. (hereinafter referred to as “Pu'an Pharmaceutical”), a holding subsidiary of the company, recently passed the GMP compliance inspection for pharmaceuticals.
No Data